Coverage
-
November 18, 2014
The Ninth Circuit sitting en banc reversed a panel decision on Tuesday remanding to California state court dozens of coordinated, multiplaintiff lawsuits alleging the pain medication propoxyphene caused cardiovascular injuries, after Teva Pharmaceuticals USA Inc. and Xanodyne Pharmaceuticals Inc. argued the cases were properly removed to federal court.
2 other articles on this case.
View all »